SLS · SELLAS Life Sciences Group, Inc.
Market Cap
$2.71B
Shares
201.95M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
154 filings
153 filers
Visit website
Investor relations